Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 18, 2024 |
| PDB ID | UniProt ID ▼ | Title | Descriptor |
|---|---|---|---|
| 7JVC | 7JVC | SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment | |
| 7JVA | 7JVA | SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment (local refinement of the receptor-binding domain and Fab variable domains) | |
| 7JV6 | 7JV6 | SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation) | |
| 7JV4 | 7JV4 | SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (one RBD open) | |
| 7JTV | 7JTV | Structure of IMPa from Pseudomonas aeruginosa in complex with an O-glycopeptide | |
| 7JTR | 7JTR | Complex of maltose-binding protein (MBP) with single-chain Fv (scFv) | |
| 7JTG | 7JTG | Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody RM11-43 | |
| 7JPI | 7JPI | Crystal structure of EBOV glycoprotein with modified HR2 stalk at 2.3A resolution | |
| 7JPH | 7JPH | Crystal structure of EBOV glycoprotein with modified HR1c and HR2 stalk at 3.2 A resolution | |
| 7JOO | 7JOO | Crystal structure of ICOS in complex with antibody STIM003 and anti-kappa VHH domain | |
| 7JN5 | 7JN5 | Crystal structure of SARS-CoV receptor binding domain in complex with human antibody CR3022 | |
| 7JMW | 7JMW | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with cross-neutralizing antibody COVA1-16 Fab | |
| 7JMP | 7JMP | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-39 | |
| 7JMO | 7JMO | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-04 | |
| 7JKT | 7JKT | Crystal structure of vaccine-elicited broadly neutralizing VRC01-class antibody 2413a in complex with HIV-1 gp120 core | |
| 7JKS | 7JKS | Crystal structure of vaccine-elicited broadly neutralizing VRC01-class antibody 2411a in complex with HIV-1 gp120 core | |
| 7JIX | 7JIX | Murine antibody that engages the influenza hemagglutinin receptor binding site | |
| 7JHH | 7JHH | Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Fab and nanobody | |
| 7JHG | 7JHG | Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Dorsomorphin (Compound C) and Fab-nanobody | |
| 7FJS | 7FJS | Crystal structure of T6 Fab bound to theSARS-CoV-2 RBD of B.1.351 | |
| 7FJO | 7FJO | Cryo-EM structure of South African (B.1.351) SARS-CoV-2 spike glycoprotein in complex with three T6 Fab | |
| 7FJN | 7FJN | Cryo-EM structure of South African (B.1.351) SARS-CoV-2 spike glycoprotein in complex with two T6 Fab | |
| 7FJC | 7FJC | Crystal structure of SARS-CoV-2 Beta RBD complexed with P36-5D2 Fab | |
| 7FIG | 7FIG | luteinizing hormone/choriogonadotropin receptor(S277I)-chorionic gonadotropin-Gs complex | |
| 7FH0 | 7FH0 | Crystallographic structure of two neutralizing nanobodies in complex with SARS-CoV-2 spike receptor-binding Domain (RBD) | |
| 7FGC | 7FGC | A naturally-occurring neuraminidase-inhibitors-resistant NA from asiatic toad influenza B-like virus | |
| 7FGB | 7FGB | A naturally-occurring neuraminidase-inhibitors-resistant NA from asiatic toad influenza B-like virus | |
| 7FCQ | 7FCQ | Crystallographic structure of neutralizing antibody P14-44 in complex with SARS-CoV-2 spike receptor-binding Domain (RBD) | |
| 7FCP | 7FCP | Crystallographic structure of two neutralizing antibodies in complex with SARS-CoV-2 spike receptor-binding Domain (RBD) | |
| 7FBP | 7FBP | FXIIa-cMCoFx1 complex | |
| 7FBL | 7FBL | Thrombocorticin in complex with Ca2+ and mannose | |
| 7FBK | 7FBK | Crystal structure of SARS-CoV-2 receptor binding domain N501Y mutant in complex with neutralizing nanobody 20G6 | |
| 7FBJ | 7FBJ | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing nanobody 17F6 | |
| 7FAT | 7FAT | Structure Determination of the RBD-NB1A7 | |
| 7FAH | 7FAH | Immune complex of head region of CA09 HA and neutralizing antibody 12H5 | |
| 7FAE | 7FAE | S protein of SARS-CoV-2 in complex bound with P36-5D2(state2) | |
| 7F9O | 7F9O | PSI-NDH supercomplex of Barley | |
| 7F9G | 7F9G | Thrombocorticin in complex with Ca2+ and fucose | |
| 7F7R | 7F7R | Enterococcus faecalis GH31 alpha-N-acetylgalactosaminidase D455N in complex with Tn antigen | |
| 7F7Q | 7F7Q | Enterococcus faecalis GH31 alpha-N-acetylgalactosaminidase D455A in complex with p-nitrophenyl alpha-N-acetylgalactosaminide | |
| 7F7E | 7F7E | SARS-CoV-2 S protein RBD in complex with A5-10 Fab | |
| 7F6Z | 7F6Z | Complex Structure of antibody BD-503 and RBD-501Y.V2 of COVID-19 | |
| 7F6Y | 7F6Y | Complex Structure of antibody BD-503 and RBD-E484K of COVID-19 | |
| 7F6G | 7F6G | Cryo-EM structure of human angiotensin receptor AT1R in complex Gq proteins and Sar1-AngII | |
| 7F5R | 7F5R | Crystal structure of SARS-CoV-2 Y453F-RBD bound to mink ACE2 | |
| 7F5H | 7F5H | The crystal structure of RBD-Nanobody complex, DL28 (SC4) | |
| 7F5G | 7F5G | The crystal structure of RBD-Nanobody complex, DL4 (SA4) | |
| 7F46 | 7F46 | Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab (state1, local refinement of the RBD, NTD and 35B5 Fab) | |
| 7F3Q | 7F3Q | SARS-CoV-2 RBD in complex with A5-10 Fab and A34-2 Fab | |
| 7F15 | 7F15 | A SARS-CoV-2 neutralizing antibody |
